Sitagliptin Added-on to Insulin Study (0431-051)

• Status: Completed
• Trial end date: 2008-10-13
• Target enrollment: 0
• Participant gender: All

Summary

A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on insulin or insulin/metformin combination therapy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patient has type 2 diabetes mellitus

• Patient is poorly controlled while on insulin or insulin and metformin

Exclusion Criteria:

• Patient has a history of type 1 diabetes mellitus or history of ketoacidosis

• Patient is taking oral antidiabetic agents other than metformin during the past 3 months

• Patient is currently on treatment with daily use of pre-prandial short-acting or rapid-acting insulin